Literature DB >> 1357762

Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.

G J LaHoste1, J F Marshall.   

Abstract

Experiments were conducted to elucidate the relationships among striatal dopamine receptor density, behavioral manifestations of D1/D2 synergism (i.e., the requirement of concomitant stimulation of D1 and D2 receptors for the expression of stereotyped sniffing, licking and gnawing), and behavioral supersensitivity to dopamine agonists. The state of D1/D2 synergism was found to be independent of striatal D1 or D2 receptor density in rats as: (1) increasing striatal D1 and/or D2 receptor density (as confirmed by quantitative receptor autoradiography) by chronic treatment with SCH 23390 (0.5 mg/kg/day for 21 days) and/or haloperidol (0.5 mg/kg/day for 21 days) did not alter the normal pattern of D1/D2 synergism as determined by behavioral responsiveness to agonist stimulation of D1 or D2 receptors, and (2) 5 days of reserpine treatment (1 mg/kg/day), although not significantly changing striatal D1 or D2 receptor density, induced a breakdown in D1/D2 synergism (i.e., behavior was elicited by independent stimulation of D1 or D2 receptors). In addition, the density of striatal D2 binding sites was not indicative of behavioral sensitivity to D2 agonists. Chronic haloperidol treatment increased behavioral sensitivity to the D2 agonist quinpirole by a factor of 2. When tested 96 h after bilateral 6-hydroxy-dopamine injections or after 5 daily reserpine injections, supersensitivity to quinpirole was at least double that following chronic haloperidol, without accompanying increases in striatal D2 density. This enhanced sensitivity to quinpirole was no greater than that observed in neurologically intact rats treated concomitantly with a maximally stimulating dose of SKF 38393. Furthermore, rats with unilateral 6-hydroxydopamine lesions that were treated chronically with eticlopride continued to rotate contralateral to the lesion in response to quinpirole despite having hemispheric symmetry of striatal D2 receptor binding. By contrast, when rats with unilateral 6-hydroxydopamine lesions were given 5 daily reserpine injections, rotation was abolished, having been replaced by intense stereotyped sniffing, indicative of bilateral supersensitivity. The results support the hypothesis that two distinct types of dopamine supersensitivity exist: a modest one associated with increased D2 density, and a more profound one associated with a breakdown in D1/D2 synergism and independent of D2 density.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357762     DOI: 10.1002/syn.890120103

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  19 in total

1.  Independent mediation of unconditioned motor behavior by striatal D1 and D2 receptors in rats depleted of dopamine as neonates.

Authors:  J P Bruno; E M Byrnes; B J Johnson
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

2.  Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression.

Authors:  J L Labandeira-Garcia; G Rozas; E Lopez-Martin; I Liste; M J Guerra
Journal:  Exp Brain Res       Date:  1996-02       Impact factor: 1.972

Review 3.  Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.

Authors:  A R Braun; M Laruelle; M M Mouradian
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum.

Authors:  S Ferré; R Schwarcz; X M Li; P Snaprud; S O Ogren; K Fuxe
Journal:  Psychopharmacology (Berl)       Date:  1994-11       Impact factor: 4.530

5.  cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum.

Authors:  M Andersson; C Konradi; M A Cenci
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

6.  The effect of dopamine D1 receptor stimulation on the up-regulation of histamine H3-receptors following destruction of the ascending dopaminergic neurones.

Authors:  J H Ryu; K Yanai; X L Zhao; T Watanabe
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

7.  Nicotine alters limbic function in adolescent rat by a 5-HT1A receptor mechanism.

Authors:  Jasmin M Dao; Susan C McQuown; Sandra E Loughlin; James D Belluzzi; Frances M Leslie
Journal:  Neuropsychopharmacology       Date:  2011-03-16       Impact factor: 7.853

Review 8.  Rhes: a GTP-binding protein integral to striatal physiology and pathology.

Authors:  Laura M Harrison
Journal:  Cell Mol Neurobiol       Date:  2012-03-27       Impact factor: 5.046

9.  Early intervention of intravenous KB220IV--neuroadaptagen amino-acid therapy (NAAT) improves behavioral outcomes in a residential addiction treatment program: a pilot study.

Authors:  Merlene Miller; Amanda L C Chen; Stan D Stokes; Susan Silverman; Abdalla Bowirrat; Matthew Manka; Debra Manka; David K Miller; Kenneth Perrine; Thomas J H Chen; John A Bailey; William Downs; Roger L Waite; Margaret A Madigan; Eric R Braverman; Uma Damle; Mallory Kerner; John Giordano; Siobhan Morse; Marlene Oscar-Berman; Debmalya Barh; Kenneth Blum
Journal:  J Psychoactive Drugs       Date:  2012 Nov-Dec

10.  The Ras homolog Rhes affects dopamine D1 and D2 receptor-mediated behavior in mice.

Authors:  Gabriel C Quintero; Daniela Spano; Gerald J Lahoste; Laura M Harrison
Journal:  Neuroreport       Date:  2008-10-29       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.